SlideShare a Scribd company logo
Presenter : Dr. Kaushik Nandi
Overview
 Historical overview
 Indications
 Contraindications
 Adverse Effects
 ECT Stimulus
 ECT Procedure
 Mechanisms of action
 Effectiveness
 Special Populations
 References
Historical overview of convulsive therapies
 The roots of Convulsive therapy can be
found in 1500s when Paracelsus gave
Camphor to patients by mouth to induce
seizures and cure psychiatric ailments.
 In 1758, the first report was published
which mentioned the use of camphor for
the treatment of mania by inducing
seizures.
 Another breakthrough was achieved in 1927 by a young
Polish neurophysiologist and neuropsychiatrist named
Manfred J. Sakel.
• Sakel discovered accidentally, by
causing convulsions with an overdose
of insulin, that the treatment was
efficient with patients afflicted with
psychosis, particularly schizophrenia
 In 1930 he began to perfect, what was to become
the "Sakel's Technique" for treating schizophrenics.
 According to his findings, more than 70 % of his patients
improved after Insulin shock therapy.
 In 1934, Hungarian Neuropsychiatrist,
Ladislas Meduna treated a patient of
catatonic schizophrenia by inducing
seizure with intra-muscular injection of
Camphor oil.
 He observed greater glial cells in
epileptics & schizophrenics have lesser
glial cells, hence he tried to increase glial
cell concentration with induced seizures
 Later camphor was replaced by
Pentamethylenetetrazol (Metrazol)
 In 1937, the Italian neuropsychiatrists
Ugo Cerletti and Lucio Bini began to
induce seizures experimentally with
electricity
 They found that seizures could be more
easily induced and regulated with
electricity than with pharmacological
agents, thereby decreasing the number of
missed or recurrent seizures
 On May 15, 1938, a seizure was
successfully elicited with electricity in a
39-year-old delirious manic man.
 After 10 to 20 ECT shocks in alternate days, the
improvement in most of the patients were startling.
 Significant improvements in the technique of ECT have
been made since then, including the use of muscle
relaxants, such as succinylcholine, the anesthesia of
patients with short-acting agents, pre-oxygenation of the
brain, the use of EEG seizure monitoring and better
devices and shock waveforms.
 Despite these advances, the popularity of ECT greatly
decreased in the 1960s and 1970s, due to the use of more
effective neuroleptics and as a result of a strong anti-ECT
movement.
 However, ECT gained evidence again in the last 15 years,
due to it's efficacy.
 It is the only somatic therapy from the 30's that remains in
widespread use today.
Carrie Fisher (Princess Leia) was treated with ECT for BPAD
Indications of ECT
1. Major depression, both unipolar and bipolar and
Psychotic depression
2. Mania
3. Schizophrenia with acute exacerbation; Catatonic
subtype, particularly
4. Schizoaffective disorder
5. High suicidal risk
6. Others: Parkinson disease, Neuroleptic malignant
disorder, Intractable Seizures
Primary Use
 Rapid definitive response required on medical or
psychiatric grounds
 Risks of alternative treatments outweighs benefits
 Past history of poor response to psychotropics or good
response to ECT
 Patient preference
Secondary Use
 Failure to respond to pharmacotherapy in the current
episode
 Intolerance of pharmacotherapy in the current episode
 Rapid definitive response necessitated by deterioration of
patient’s condition
Contraindications
 ECT has no absolute contraindications.
Medical conditions associated with increased risk:
 Space-occupying intracerebral lesion (tumor, hematoma,
etc.)
 Other condition causing increased intracranial pressure
 Recent myocardial infarction
 Recent intracerebral hemorrhage
 Unstable vascular aneurysm or malformation
 Pheochromocytoma
 High anesthesia risk (American Society of
Anesthesiologists [ASA] class 4 or 5)
Mortality Rate
 Extremely low, estimated at 2–10 per 100,000 patients
(0.0001%) - same ratio as for the induction of brief
general anesthesia
Cognitive Changes
 Cognitive changes are often the most notable and most
distressing side effects
Factors that may increase cognitive side effects
Postictal Disorientation:
 All patients experience some transient postictal
disorientation, lasting from a few minutes to a few hours,
following awakening from the ECT treatment.
 Having received general anesthesia likely contributes to
this disorientation
Interictal Confusion:
 Occasionally, postictal confusion may not fully disappear
and, when severe, may develop into an interictal
confusional state or delirium.
 Uncommon
 Rapidly disappears over a period of days following the
conclusion of treatments
 The ECT team at NIMHANS has developed and validated
a short and sensitive battery (Battery For ECT Related
Cognitive Deficits – B4ECT-ReCoDe) for a quick
assessment of cognitive deficits associated with ECT in
the Indian setting
Cardiovascular Complications
 They are the main cause of mortality and serious
morbidity with ECT, although most such complications
are minor.
 During the seizure and acute postictal period, both the
sympathetic and parasympathetic autonomic systems are
sequentially stimulated.
 Activation of the parasympathetic system causes a
transient reduction in cardiac rate
 Activation of the sympathetic system increases heart rate,
blood pressure, and myocardial oxygen consumption.
 These changes occasionally giving rise to transient
arrhythmias and, in susceptible individuals, transient
ischemic changes.
 During parasympathetic stimulation, cardiac arrhythmias,
such as bradycardia, premature ventricular contractions, or
sinus arrest, may be seen.
 The risks of cardiac arrhythmias, ischemia, and
hypertension are greatly diminished by the use of
oxygenation before and during the seizure, and these risks
can be lowered further in susceptible patients by
pretreatment with appropriate medications.
 Stress on the heart during ECT equivalent to
climbing up about 2 floors.
Other Adverse Effects
 General somatic complaints (e.g., headaches, nausea,
muscle soreness) are usually minor but are frequent
side effects of ECT.
 Lasting up to several hours, but occasionally longer.
 A soft bite block or other such device is used to
prevent injury to the tongue or teeth
ECT Stimulus
 Generation & behaviour of
electrical stimulus has been
conceptualized by Ohm’s law:
 V (voltage) = I (current) × R
(resistance)
1. Waveform of the stimulus:
 Earlier ECT machines delivered current in the form of
sine waves.
 The slow rising and trailing edges of the sine wave do not
produce efficient cerebral stimulation.
 This delivers substantial amounts of electrical stimulation
below seizure threshold and continues stimulation even
while the neuronal tissue is in post-depolarization
refractory period.
 This may increase the cognitive adverse effects without
enhancing the benefits.
 Hence, the sine wave has been modified to eliminate the
rising and trailing edges, retaining only the peaks in the
form of ‘rectangular’ pulses
 Stimulus is given in the form of brief pulses (0.5ms) with
no stimulus in between the pulses.
 Intermittent stimulation using pulses is more efficient as it
allows the tissue to recover from post-depolarization
refractory period.
 Brief pulse ECT is able to induce seizures with
substantially less charge and energy compared to sine
wave.
 Pulse width – 0.5-2ms: brief pulse
<0.5ms: ultra-brief
 Stimulus duration - total period for which the stimulus
train is applied
Sine wave – less than 1s
Pulse wave – 0.5 – 8s
 In the brief pulse ECT, the actual duration of stimulus will
be even lesser if the inter-train interval (where stimulus
is not provided) is excluded.
Frequency - number of cycles per second (Hz)
 In the transformer-based sine wave stimuli, this is always
the line frequency (50Hz or 60 Hz)
 Brief pulse – pulses per second (PPS)
Directionality & Polarity : Stimulus in ECT is
bidirectional, alternating current
Pulse amplitude:
 The amplitude of the delivered current is an important
determinant of the volume of nervous tissue that is
directly stimulated by the ECT.
 Modern ECT uses a constant current of around 800-
900mA
Charge:
 Total amount of electrons traversing the inter-electrode
tissue
 It is the product of current and actual duration of stimulus
in milli-Coulomb (mC)
 Charge = current (in Amperes) × pulse width (in
milliseconds) × pulse frequency × length of train (in
seconds)
2. STIMULUS INTENSITY
 Determines treatment efficacy & cognitive adverse
effects; measured as charge in mC
 Stimulus threshold should be supra-threshold to be
efficacious
 Bilateral ECT – 1.5 to 2.5 times threshold
 Unilateral ECT – 2.5 to 6 times threshold
3. ELECTRODE PLACEMENT
Unilateral ECT
 Stimulus is provided to only one hemisphere (usually
right) to minimize cognitive dysfunction
 Electrode 1: Fronto-temporal site i.e., 1 inch above the
midpoint of an imaginary line linking the outer canthus
and the external auditory meatus
 Electrode 2: 1 inch lateral to the vertex position, on the
same side (usually right)
Bilateral ECT
 Bifrontal placement - electrodes are placed 5 cm vertically
above the outer canthus of each eye along an imaginary
vertical line perpendicular to a line connecting the pupils
 Bitemporal placement - electrodes are placed on the
frontotemporal sites, one on each side
Electrode Placements
Bitemporal Right unilateral /
d’Elia
Bifrontal /
Letemendia
Selective Preferences Of Electrode Placement
Unilateral ECT
• Concern about potential cognitive side-effects (children,
elderly, brain damaged)
• Instrument limitations (e.g., sine wave stimulus)
Bilateral ECT
• Mania or schizo-affective disorder
• Patient has not satisfactorily responded to UL ECT
(usually after 6 ECTs)
• When more urgent response is essential (suicidal, starving
etc)
4. FREQUENCY OF TREATMENTS
 ECT is generally administered twice or thrice a week
 However, it is recommended that the patient be evaluated
both for therapeutic and adverse effects
5. NUMBER OF SESSIONS
 Decided based on the degree and rate of clinical
improvement and adverse effects
 A typical course of ECT for depression consists of 6 to 12
sessions
 Continuation ECT - begins after the index course, lasts
up to 6 months, and is designed to prevent relapse of the
episode
 Maintenance ECT - to prevent further episodes for
longer periods
 Frequency of ECT is slowly tapered off to once a month
ECT Procedure
 Administration of ECT without a muscle relaxant is
known as unmodified ECT.
 In modified ECT, anesthesia, muscle relaxant, and the
seizure-eliciting electrical stimulus are administered in the
same order.
 Use of a muscle relaxant prevents musculoskeletal injuries
resulting from peripheral seizures
Preparation of patient:
 Avoid solid food for at least 6 hours before treatment.
 Moderate amounts of clear fluids can be taken till 2 hours
 Oral medications should be taken 2 hours before treatment
 Pass urine to prevent bladder rupture during ECT.
 Dentures, jewellery, hair clips, contact lenses and hearing
aids should be removed.
 Hair should be dry and clean.
Modification Procedures:
 Short acting barbiturates are commonly used as induction
agents. E.g: Thiopentone (3-5 mg/kg)
 Succinylcholine (0.5-1 mg/kg) is the preferred muscle
relaxant due to its rapid onset, short duration of action,
and rapid recovery.
 Patient is allowed to breathe 100% oxygen through face
mask for 3 minutes at 15 -20 breaths per minute
 Atropine (0.6 mg) given along with intravenous anesthetic
helps in preventing vagal effects of electrical stimulation
on heart
 Seizure Monitoring:
1. Cuff method
2. EEG monitoring
 Cuff method:
Technique
 Place the BP cuff (preferably between knee and ankle). If
unilateral ECT is used cuff should be attached to the right
side (ipsilateral) to confirm generalization of seizures.
 Just prior to the injection of succinylcholine inflate the
cuff to a pressure 50 - 80 mm Hg above systolic blood
pressure.
 Observe that fasciculation after succinylcholine injection,
which appear in other parts of the body do not appear in
the isolated limb.
 Apply the stimulus and note the time.
 At the start of tonic phase of seizure release the cuff.
 Record the total duration of tonic and clonic phases till the
last clonic movement
EEG monitoring:
 Although not mandatory, it has distinct advantages and is
recommended where possible as it is the most direct
measure of cerebral activity available.
 The length of the convulsions measured by direct
visualization is approximately 70% that of EEG seizures
Schematic of various phases of a typical ECT seizure.
Motor and EEG ictal responses during ECT
Stage Motor response EEG response
Onset- epileptic recruiting
rhythm
- 10 Hz waves with increasing
amplitude
Tonic phase- polyspikes Tonic muscular
contractions
Bursts of high amplitude
spike discharges lasting 10-
15 seconds
Tonic –clonic phase –
polyspike and slow wave
complexes
Regular myoclonic
contractions
Polyspikes intermixed with
slow waves
Post- ictal cortical extinction Post-ictal sleep Isoelectric or flat EEG
Recovery Gradual regaining of
consciousness
Resumption of delta, then
theta & then alpha activity
Determination of Seizure Adequacy
 Achievement of an adequate seizure duration has been
assumed to be both necessary and sufficient to ensure
therapeutic adequacy of ECT treatment
 20- second motor response and/or
 25-second EEG response
Other Physiological Monitoring:
 Vital signs such as Blood pressure and Pulse should be
recorded before and after ECT.
 ECG monitoring is considered mandatory during ECT
procedure.
 Pulse oximetry
 Missed seizure, inadequate and prolonged seizures are
known phenomena during ECT.
 These are dependent on the seizure threshold.
 The threshold is lower in a) young subjects, b) manic
patients, and c) during the first ECT session.
 Conversely, benzodiazepines, carbamazepine and
thiopentone elevate the threshold.
Missed seizures:
 When electrical stimulation is not followed by any motor
or EEG seizure activity, it is termed a missed seizure.
 Wait for 20 seconds before restimulation to allow for
delayed onset of seizures.
 Restimulation should occur only after 45 seconds with
higher dosage.
Methods of managing missed seizure :
 Change of anesthetic agent to Etomidate or Ketamine
 Vigorous hyperventilation
 Use of EEG monitoring
 Change to bilateral ECT, as the seizure threshold is high
with unilateral ECT
 Reducing the frequency of sessions
 Reducing the frequency of sessions (from 3/wk to 2/wk)
can facilitate adequate seizures
 Lower change rate by shortening pulse width or increasing
interpulse intervals by decreasing frequency of stimulus
 Avoiding / reducing the dosage of Anti-epileptics and
Benzodiazepines.
Prolonged seizure:
 In most situations, the seizure terminates within 100
seconds.
 The American Psychiatric Association task force defines a
prolonged seizure if seizure duration is beyond 180
seconds.
 Prolonged seizures can be terminated by intravenous
diazepam 10 mg. or thiopentone 100-200mg
Mechanisms of action of ECT
Mechanisms of action of ECT have been studied in five
important domains:
1. Neuroplasticity
2. Contribution of EEG correlates
3. Neurophysiology
4. Neurotransmitters
5. Neuroendocrinology
Neuroplasticity:
 This happens through remodelling of synapses, generation
of new neurons, proliferation of glial cells, and
improvement in blood supply in specific brain areas.
 Animal studies have more robust findings favouring the
role of ECT in promoting neuroplasticity, particularly in
hippocampus, and recently in the prefrontal cortex and
amygdala also
 Serum levels of BDNF, an important neurotrophin
regulating synaptogenesis and neuronal cell growth, have
been found to be increased following ECT.
 One study demonstrated increases in volumes of amygdala
and prefrontal cortex.
Contribution of EEG correlates :
Anticonvulsant theory:
 Gradual increase in seizure threshold occurs over the
course of successive ECT sessions.
 The plasma levels of inhibitory neurotransmitter GABA
has been noted to increase following ECT
 Hence, it has been postulated that the clinical
improvements following ECT are not due to seizure per
se, but due to the brain’s efforts to reduce the probability
of occurrence of subsequent seizures
Connectivity Resetting :
 This is supported by the finding that ECT leads to
frequency specific modification of theta activity and
reduced blood flow in the Subgenual, ACC, Medial frontal
cortex, and increased blood flow to the Thalamus
 Thus, it is postulated that ECT rectifies the aberrant
modulatory activity of alpha and theta oscillations by the
thalamus.
 It stimulates the thalamo-cortical loop, takes over the
thalamic pacemaker function, resets it, and restores the
functional connectivity and control between various brain
areas.
Neurophysiology:
 The related hypothesis is called “Reducing
Hyperconnectivity”.
 ECT produces post-ictal states of diffuse slowing of
EEG with high amplitude delta and theta activity.
 This is followed by a period of post-ictal suppression,
which initially lasts for few hours after each ECT
session.
 This slowing gradually prolongs over many sessions of
ECT into an inter-ictal suppression
 PET and SPECT studies have also shown decreased blood
flow and glucose metabolism in the frontal lobe, following
ECT.
 Functional MRI studies are few, but they have
corroborated the reduced functional connectivity in frontal
cortex post-ECT.
 Overall, it can be assumed that ECT reduces the
“hyperconnectivity” secondary to depression in the frontal
cortex, particularly in the VMPFC, DMPFC, and some
parts of ACC.
Neurotransmitters :
 ECT has been found to affect 5-HT, DA, and adrenergic
system. More pronounced on DA than on 5-HT and
adrenaline.
 Increased dopamine release consistently in the striatum,
and inconsistently in the frontal and occipital regions.
 It also causes up-regulation of DRD1 and DRD3 receptors
 There is evidence of inhibition of adrenergic α2 auto
receptors by ECT, resulting in increased secretion of
catecholamines.
 ECT increases concentrations of glutamine, (a metabolite
of glutamate) and N-acetyl aspartate, a neuronal marker in
the ACC, PFC, and amygdala. This supports the
neuroplastic hypothesis of ECT.
 ECT also increases GABA levels, particularly in ACC,
PFC, and occipital cortex, thus reinforcing the
anticonvulsant hypothesis.
Neuroendocrinology:
 Neuroendocrine-diencephalic theory of depression
hypothesized that the HPA axis is disturbed producing a
state of hypercortisolemia and abnormal DST
 ACTH, cortisol and prolactin levels increased soon after a
session of ECT and came down to normal level within few
hours.
 Normalisation of DST has been correlated with clinical
response
Major depressive disorder
 ECT was found to be 20 to 40% more effective than
medications
 Response to ECT in antidepressant non-responders is
around 50 to 70 %
Effectiveness of ECT
 Comparison of ECT versus antidepressants (MAOI &
TCA) - a significant superior effect of ECT noted
- Gangadhar BN et al (1982), Pagnin D et al
 An RCT found ECT to be superior to paroxetine in
medication-resistant major depression, in terms of both
degree and speed of response
- Folkerts HW et al
 Equal efficacy in unipolar & bipolar depression –
- Narayanaswamy JC et al
 ECT is an effective short-term treatment for depression,
and is probably more effective than drug therapy. Bilateral
ECT is moderately more effective than unilateral ECT,
and high dose ECT is more effective than low dose
- UK ECT Review Group.
Mania:
 Second-line treatment (CANMAT, APA), third-line
(NICE)
 Response rates 75-80%; Increased responsiveness in rapid
cyclers & mixed affective states
 Controlled retrospective comparisons have found ECT to
be equivalent to lithium, & at least as efficacious as
typical neuroleptics
Schizophrenia:
 Indicated in treatment-resistant patients and those who
relapse on monotherapy
 Combination treatment is more effective than ECT alone,
& more effective than medications alone
 Equivalent to pharmacotherapy in management of NMS;
superior in that it treats underlying condition where
neuroleptics cannot be used
 Response to ECT among a group of adolescents was
around 76%. The main diagnosis was schizophrenia &
MDD
- Grover et al, 2013
 Another study on children with a predominant diagnosis
of catatonia showed ECT was efficacious in 77.3%
patients
– Jacob et al, 2014
Delirium tremens:
 ECT is an effective method of suppressing the symptoms
of delirium associated with alcohol withdrawal
 In all cases, one treatment produced a period of sedation
followed by a clearing of the sensorium and termination of
hallucinations within 24 hours.
-William H. C. Dudley, Jr. and J. G. Williams
ECT in Special Populations
Elderly population:
ECT is particularly useful in the elderly
 Medication intolerance is common
 Drug interactions are common
 Cognitive side effects are more common
 Response to ECT is better in the elderly
 Seizure threshold is greater ⇒ It may be difficult to get
adequate seizures
Pregnancy:
 Use of psychotropics is associated with problems in first
and last trimester
 Untreated psychiatric disorders may have adverse effect
on the baby
 ECT is effective
 Many guidelines on mood disorders advocate use of ECT
as first line treatment for major depression and mania in
first trimester
 APA Taskforce on ECT: “low risk and high efficacy in
the management of specific disorders in all three
trimesters of pregnancy”
Children and adolescents:
 ECT should be used with extreme caution (and very rarely
as a first-line treatment) in young people because of the
lack of evidence from randomised controlled trials
 Seizure threshold is low
 Propensity for prolonged seizures
 Two consultants need to independently opinion about the
need for ECT
Relapse after ECT
 51.1% of patients (depression) relapsed by 12 months
following successful initial treatment with ECT, with the
majority (37.7%) relapsing within the first 6 months
-Ana Jelovac et al
 C-ECT and continuation pharmacotherapy may be more
effective than either alone for preventing relapse.
-Nagy A. Youssef et al
References:
 Gangadhar BN, Sundar AS, Thirthalli J, Varambally S, Muralidharan J,
Kumar CN et al. ECT Administration manual. 2nd ed. Bangalore:
NIMHANS; 2013
 Max Fink. Convulsive therapy: a review of the first 55 years. Journal of
Affective Disorders 63 (2001) 1–15
 UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in
depressive disorders: a systematic review and meta-analysis. Lancet. 2003
Mar 8;361(9360):799-808
 Gangadhar BN, Viswanath B, Keshavan M, Sundar AS. Hnadbook of
Electroconvulsive therapy. Bangalore: NIMHANS; 2015.
 Ziad Nahas, Jeffrey P. Lorberbaum, Frank A. Kozel, Mark S. George.
Somatic Treatments In Psychiatry. Textbook of Biological Psychiatry.
Wiley-Liss. 2004. 521-48.
 Mankad MV, Beyer JL, Weiner RD, Krystal AD. Clinical Manual of
Electroconvulsive Therapy. First Edition. . Washington DC. American
Psychiatric Publishing; 2010
 Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful
electroconvulsive therapy for major depression: a meta-analysis.
Neuropsychopharmacology. 2013;38(12):2467-74.
 Youssef NA, McCall WV. Relapse prevention after index electroconvulsive
therapy in treatment-resistant depression. Ann Clin Psychiatry.
2014;26(4):288-96.
 Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in
depression: a meta-analytic review. J ECT 2004 Mar;20(1):13-20.
 Gangadhar BN, Kapur RL, Kalyanasundaram S. Comparison of
electroconvulsive therapy with imipramine in endogenous depression: a
double blind study. Br J Psychiatry 1982 Oct; 141():367-71.
 Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze-
Mönking H. Electroconvulsive therapy vs. paroxetine in treatment-resistant
depression -- a randomized study. Acta Psychiatr Scand 1997
Nov;96(5):334-42.
 Grover S, Malhotra S, Varma S, Chakrabarti S, Avasthi A, Mattoo SK.
Electroconvulsive therapy in adolescents: A retrospective study from north
India. J ECT 2013;29:122-6.
 Narayanaswamy JC, Viswanath B, Reddy PV, Kumar KR, Thirthalli J,
Gangadhar BN. Efficacy of ECT in bipolar and unipolar depression in a real
life hospital setting. Asian J Psychiatry 2104;8:43-6.
 William H. C. Dudley, J. G. Williams. Electroconvulsive Therapy in
Delirium Tremens. Comprehensive Psychiatry, Vol.13, No.4
(July/August),1972
 Jacob P, Gogi PK, Srinath S, Thirthalli J, Girimaji S, Seshadri S, et al.
Review of electroconvulsive therapy practice from a tertiary child and
adolescent psychiatry centre. Asian J Psychiatr 2014;12:95-9.
THANK YOU

More Related Content

What's hot

Psychopathology of delusion
Psychopathology of delusionPsychopathology of delusion
Psychopathology of delusion
Azfer Ibrahim
 
rTMS technique
rTMS technique rTMS technique
rTMS technique
drshravan
 
Psychopathology depression
Psychopathology depressionPsychopathology depression
Psychopathology depression
ehab elbaz
 
Treatment resistant schizophrenia
Treatment resistant schizophreniaTreatment resistant schizophrenia
Treatment resistant schizophrenia
GAURAVUPPAL23
 
Ocd overview
Ocd overviewOcd overview
Ocd overview
Anant Rathi
 
Treatment resistant schizophrenia & Treatment resistant depression
Treatment resistant schizophrenia & Treatment resistant depressionTreatment resistant schizophrenia & Treatment resistant depression
Treatment resistant schizophrenia & Treatment resistant depression
Enoch R G
 
Mini mental status examination
Mini mental status examinationMini mental status examination
Mini mental status examinationNursing Path
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
Nithiy Uday
 
Psychiatric problems among elderly
Psychiatric problems  among elderlyPsychiatric problems  among elderly
Psychiatric problems among elderlySabitha Jain
 
Geriatric psychiatry
Geriatric psychiatryGeriatric psychiatry
Geriatric psychiatry
Ravi Soni
 
hebephrenic (disorganized) and post schizophrenic depression
hebephrenic (disorganized) and post schizophrenic depressionhebephrenic (disorganized) and post schizophrenic depression
hebephrenic (disorganized) and post schizophrenic depression
SuparnaDasNaskar
 
Disorders of thought
Disorders of thoughtDisorders of thought
Disorders of thought
DrTanushiTambi
 
Neurobiology of OCD
Neurobiology of OCDNeurobiology of OCD
Neurobiology of OCD
Cijo Alex
 
Electroconvulsive therapy part 1, 2, 3
Electroconvulsive therapy part 1, 2, 3Electroconvulsive therapy part 1, 2, 3
Electroconvulsive therapy part 1, 2, 3
RAM Reddy
 
Organic mental disorder
Organic mental disorderOrganic mental disorder
Organic mental disorder
Priyanka Kumari
 
Psychopathology of ocd and bdd
Psychopathology of ocd and bddPsychopathology of ocd and bdd
Psychopathology of ocd and bdd
Varun Muthuchamy
 
Mood Disorders
Mood DisordersMood Disorders
Mood Disorders
Shimla
 
Delusional Disorder
Delusional DisorderDelusional Disorder
Delusional Disorderguest03f2b1
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
Annie Mirza
 

What's hot (20)

Psychopathology of delusion
Psychopathology of delusionPsychopathology of delusion
Psychopathology of delusion
 
rTMS technique
rTMS technique rTMS technique
rTMS technique
 
Psychopathology depression
Psychopathology depressionPsychopathology depression
Psychopathology depression
 
Treatment resistant schizophrenia
Treatment resistant schizophreniaTreatment resistant schizophrenia
Treatment resistant schizophrenia
 
Ocd overview
Ocd overviewOcd overview
Ocd overview
 
Treatment resistant schizophrenia & Treatment resistant depression
Treatment resistant schizophrenia & Treatment resistant depressionTreatment resistant schizophrenia & Treatment resistant depression
Treatment resistant schizophrenia & Treatment resistant depression
 
Mini mental status examination
Mini mental status examinationMini mental status examination
Mini mental status examination
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
 
Psychiatric problems among elderly
Psychiatric problems  among elderlyPsychiatric problems  among elderly
Psychiatric problems among elderly
 
Presentation on mania
Presentation on maniaPresentation on mania
Presentation on mania
 
Geriatric psychiatry
Geriatric psychiatryGeriatric psychiatry
Geriatric psychiatry
 
hebephrenic (disorganized) and post schizophrenic depression
hebephrenic (disorganized) and post schizophrenic depressionhebephrenic (disorganized) and post schizophrenic depression
hebephrenic (disorganized) and post schizophrenic depression
 
Disorders of thought
Disorders of thoughtDisorders of thought
Disorders of thought
 
Neurobiology of OCD
Neurobiology of OCDNeurobiology of OCD
Neurobiology of OCD
 
Electroconvulsive therapy part 1, 2, 3
Electroconvulsive therapy part 1, 2, 3Electroconvulsive therapy part 1, 2, 3
Electroconvulsive therapy part 1, 2, 3
 
Organic mental disorder
Organic mental disorderOrganic mental disorder
Organic mental disorder
 
Psychopathology of ocd and bdd
Psychopathology of ocd and bddPsychopathology of ocd and bdd
Psychopathology of ocd and bdd
 
Mood Disorders
Mood DisordersMood Disorders
Mood Disorders
 
Delusional Disorder
Delusional DisorderDelusional Disorder
Delusional Disorder
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 

Similar to Role of ECT in psychiatry

Electroconvulsive therapy
Electroconvulsive therapyElectroconvulsive therapy
Electroconvulsive therapy
Sabahuddin Ammar
 
Clinical teaching on electro convulsive therapy
Clinical teaching on electro convulsive therapyClinical teaching on electro convulsive therapy
Clinical teaching on electro convulsive therapy
Prakash Pv
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
suswara
 
electroconvulsive therapy ect
electroconvulsive therapy ectelectroconvulsive therapy ect
electroconvulsive therapy ect
AP Singh
 
Electroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT) Electroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT) Meril Manuel
 
Electro convulsive therapy (ECT)
Electro convulsive therapy (ECT)Electro convulsive therapy (ECT)
Electro convulsive therapy (ECT)
Loganathan Nsg
 
ECT- Electroconvulsive Therapy
ECT- Electroconvulsive TherapyECT- Electroconvulsive Therapy
ECT- Electroconvulsive Therapy
kkapil85
 
Electroconvulsive Therapy
Electroconvulsive TherapyElectroconvulsive Therapy
Electroconvulsive Therapy
Rooban Thavarajah
 
ECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptx
ECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptxECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptx
ECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptx
suhanimunjal27
 
ECT - electroconvulsive therapy
ECT - electroconvulsive therapyECT - electroconvulsive therapy
ECT - electroconvulsive therapy
Chandni Narayan
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
BRAKFOUNDATION
 
Electroconvulsive therapy
Electroconvulsive therapyElectroconvulsive therapy
Electroconvulsive therapy
Mohamed Abdelghani
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
Peehu Pandya Bhatt
 
Non pharmacological Treatments in Psychiatry
Non pharmacological Treatments in PsychiatryNon pharmacological Treatments in Psychiatry
Non pharmacological Treatments in Psychiatry
Dr Bhakti Murkey
 
ECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptx
ECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptxECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptx
ECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptx
RobinBaghla
 
Electro convulsive therapy final. ppt
Electro convulsive therapy final. pptElectro convulsive therapy final. ppt
Electro convulsive therapy final. pptSathish Rajamani
 
PRESENTATION 8_081830.pptx
PRESENTATION 8_081830.pptxPRESENTATION 8_081830.pptx
PRESENTATION 8_081830.pptx
AsifiweMwaikambo
 

Similar to Role of ECT in psychiatry (20)

Electroconvulsive therapy
Electroconvulsive therapyElectroconvulsive therapy
Electroconvulsive therapy
 
Ect
EctEct
Ect
 
Clinical teaching on electro convulsive therapy
Clinical teaching on electro convulsive therapyClinical teaching on electro convulsive therapy
Clinical teaching on electro convulsive therapy
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
 
electroconvulsive therapy ect
electroconvulsive therapy ectelectroconvulsive therapy ect
electroconvulsive therapy ect
 
Electroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT) Electroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT)
 
Electro convulsive therapy (ECT)
Electro convulsive therapy (ECT)Electro convulsive therapy (ECT)
Electro convulsive therapy (ECT)
 
ECT- Electroconvulsive Therapy
ECT- Electroconvulsive TherapyECT- Electroconvulsive Therapy
ECT- Electroconvulsive Therapy
 
Electroconvulsive Therapy
Electroconvulsive TherapyElectroconvulsive Therapy
Electroconvulsive Therapy
 
ECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptx
ECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptxECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptx
ECT PROCEDUmmmmmmmmmmmmmmRE....2023.pptx
 
ECT - electroconvulsive therapy
ECT - electroconvulsive therapyECT - electroconvulsive therapy
ECT - electroconvulsive therapy
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
 
Electroconvulsive therapy
Electroconvulsive therapyElectroconvulsive therapy
Electroconvulsive therapy
 
Electro convulsive therapy
Electro convulsive therapyElectro convulsive therapy
Electro convulsive therapy
 
Non pharmacological Treatments in Psychiatry
Non pharmacological Treatments in PsychiatryNon pharmacological Treatments in Psychiatry
Non pharmacological Treatments in Psychiatry
 
ECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptx
ECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptxECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptx
ECT.yssuusjjjxnxnzhzsjajsjjsjzjzznznznpptx
 
ECT Part I
ECT Part IECT Part I
ECT Part I
 
Electro convulsive therapy final. ppt
Electro convulsive therapy final. pptElectro convulsive therapy final. ppt
Electro convulsive therapy final. ppt
 
PRESENTATION 8_081830.pptx
PRESENTATION 8_081830.pptxPRESENTATION 8_081830.pptx
PRESENTATION 8_081830.pptx
 
NIBS
NIBSNIBS
NIBS
 

More from Dr Kaushik Nandy

Treatment resistant Schizophrenia
Treatment resistant SchizophreniaTreatment resistant Schizophrenia
Treatment resistant Schizophrenia
Dr Kaushik Nandy
 
Theory Of Learning (Psychology)
Theory Of Learning (Psychology)Theory Of Learning (Psychology)
Theory Of Learning (Psychology)
Dr Kaushik Nandy
 
Clinical features and Management of Schizophrenia
Clinical features and Management of SchizophreniaClinical features and Management of Schizophrenia
Clinical features and Management of Schizophrenia
Dr Kaushik Nandy
 
National mental health program (NMHP)
National mental health program (NMHP)National mental health program (NMHP)
National mental health program (NMHP)
Dr Kaushik Nandy
 
Sleep disorders
Sleep disordersSleep disorders
Sleep disorders
Dr Kaushik Nandy
 
Neuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsyNeuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsy
Dr Kaushik Nandy
 
Depression and other Affective disorders
Depression and other Affective disordersDepression and other Affective disorders
Depression and other Affective disorders
Dr Kaushik Nandy
 
etiopathogenesis of Schizophrenia
etiopathogenesis of Schizophreniaetiopathogenesis of Schizophrenia
etiopathogenesis of Schizophrenia
Dr Kaushik Nandy
 
Temporal lobe and its role in psychiatry
Temporal  lobe  and  its  role  in  psychiatryTemporal  lobe  and  its  role  in  psychiatry
Temporal lobe and its role in psychiatry
Dr Kaushik Nandy
 

More from Dr Kaushik Nandy (9)

Treatment resistant Schizophrenia
Treatment resistant SchizophreniaTreatment resistant Schizophrenia
Treatment resistant Schizophrenia
 
Theory Of Learning (Psychology)
Theory Of Learning (Psychology)Theory Of Learning (Psychology)
Theory Of Learning (Psychology)
 
Clinical features and Management of Schizophrenia
Clinical features and Management of SchizophreniaClinical features and Management of Schizophrenia
Clinical features and Management of Schizophrenia
 
National mental health program (NMHP)
National mental health program (NMHP)National mental health program (NMHP)
National mental health program (NMHP)
 
Sleep disorders
Sleep disordersSleep disorders
Sleep disorders
 
Neuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsyNeuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsy
 
Depression and other Affective disorders
Depression and other Affective disordersDepression and other Affective disorders
Depression and other Affective disorders
 
etiopathogenesis of Schizophrenia
etiopathogenesis of Schizophreniaetiopathogenesis of Schizophrenia
etiopathogenesis of Schizophrenia
 
Temporal lobe and its role in psychiatry
Temporal  lobe  and  its  role  in  psychiatryTemporal  lobe  and  its  role  in  psychiatry
Temporal lobe and its role in psychiatry
 

Recently uploaded

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 

Role of ECT in psychiatry

  • 1. Presenter : Dr. Kaushik Nandi
  • 2. Overview  Historical overview  Indications  Contraindications  Adverse Effects  ECT Stimulus  ECT Procedure  Mechanisms of action  Effectiveness  Special Populations  References
  • 3. Historical overview of convulsive therapies  The roots of Convulsive therapy can be found in 1500s when Paracelsus gave Camphor to patients by mouth to induce seizures and cure psychiatric ailments.  In 1758, the first report was published which mentioned the use of camphor for the treatment of mania by inducing seizures.
  • 4.  Another breakthrough was achieved in 1927 by a young Polish neurophysiologist and neuropsychiatrist named Manfred J. Sakel. • Sakel discovered accidentally, by causing convulsions with an overdose of insulin, that the treatment was efficient with patients afflicted with psychosis, particularly schizophrenia
  • 5.  In 1930 he began to perfect, what was to become the "Sakel's Technique" for treating schizophrenics.  According to his findings, more than 70 % of his patients improved after Insulin shock therapy.
  • 6.  In 1934, Hungarian Neuropsychiatrist, Ladislas Meduna treated a patient of catatonic schizophrenia by inducing seizure with intra-muscular injection of Camphor oil.  He observed greater glial cells in epileptics & schizophrenics have lesser glial cells, hence he tried to increase glial cell concentration with induced seizures
  • 7.  Later camphor was replaced by Pentamethylenetetrazol (Metrazol)  In 1937, the Italian neuropsychiatrists Ugo Cerletti and Lucio Bini began to induce seizures experimentally with electricity
  • 8.  They found that seizures could be more easily induced and regulated with electricity than with pharmacological agents, thereby decreasing the number of missed or recurrent seizures  On May 15, 1938, a seizure was successfully elicited with electricity in a 39-year-old delirious manic man.
  • 9.  After 10 to 20 ECT shocks in alternate days, the improvement in most of the patients were startling.  Significant improvements in the technique of ECT have been made since then, including the use of muscle relaxants, such as succinylcholine, the anesthesia of patients with short-acting agents, pre-oxygenation of the brain, the use of EEG seizure monitoring and better devices and shock waveforms.
  • 10.  Despite these advances, the popularity of ECT greatly decreased in the 1960s and 1970s, due to the use of more effective neuroleptics and as a result of a strong anti-ECT movement.  However, ECT gained evidence again in the last 15 years, due to it's efficacy.  It is the only somatic therapy from the 30's that remains in widespread use today.
  • 11. Carrie Fisher (Princess Leia) was treated with ECT for BPAD
  • 12. Indications of ECT 1. Major depression, both unipolar and bipolar and Psychotic depression 2. Mania 3. Schizophrenia with acute exacerbation; Catatonic subtype, particularly 4. Schizoaffective disorder 5. High suicidal risk 6. Others: Parkinson disease, Neuroleptic malignant disorder, Intractable Seizures
  • 13. Primary Use  Rapid definitive response required on medical or psychiatric grounds  Risks of alternative treatments outweighs benefits  Past history of poor response to psychotropics or good response to ECT  Patient preference
  • 14. Secondary Use  Failure to respond to pharmacotherapy in the current episode  Intolerance of pharmacotherapy in the current episode  Rapid definitive response necessitated by deterioration of patient’s condition
  • 15. Contraindications  ECT has no absolute contraindications. Medical conditions associated with increased risk:  Space-occupying intracerebral lesion (tumor, hematoma, etc.)  Other condition causing increased intracranial pressure  Recent myocardial infarction  Recent intracerebral hemorrhage
  • 16.  Unstable vascular aneurysm or malformation  Pheochromocytoma  High anesthesia risk (American Society of Anesthesiologists [ASA] class 4 or 5) Mortality Rate  Extremely low, estimated at 2–10 per 100,000 patients (0.0001%) - same ratio as for the induction of brief general anesthesia
  • 17. Cognitive Changes  Cognitive changes are often the most notable and most distressing side effects Factors that may increase cognitive side effects
  • 18. Postictal Disorientation:  All patients experience some transient postictal disorientation, lasting from a few minutes to a few hours, following awakening from the ECT treatment.  Having received general anesthesia likely contributes to this disorientation
  • 19. Interictal Confusion:  Occasionally, postictal confusion may not fully disappear and, when severe, may develop into an interictal confusional state or delirium.  Uncommon  Rapidly disappears over a period of days following the conclusion of treatments
  • 20.  The ECT team at NIMHANS has developed and validated a short and sensitive battery (Battery For ECT Related Cognitive Deficits – B4ECT-ReCoDe) for a quick assessment of cognitive deficits associated with ECT in the Indian setting
  • 21. Cardiovascular Complications  They are the main cause of mortality and serious morbidity with ECT, although most such complications are minor.  During the seizure and acute postictal period, both the sympathetic and parasympathetic autonomic systems are sequentially stimulated.  Activation of the parasympathetic system causes a transient reduction in cardiac rate
  • 22.  Activation of the sympathetic system increases heart rate, blood pressure, and myocardial oxygen consumption.  These changes occasionally giving rise to transient arrhythmias and, in susceptible individuals, transient ischemic changes.  During parasympathetic stimulation, cardiac arrhythmias, such as bradycardia, premature ventricular contractions, or sinus arrest, may be seen.
  • 23.  The risks of cardiac arrhythmias, ischemia, and hypertension are greatly diminished by the use of oxygenation before and during the seizure, and these risks can be lowered further in susceptible patients by pretreatment with appropriate medications.  Stress on the heart during ECT equivalent to climbing up about 2 floors.
  • 24. Other Adverse Effects  General somatic complaints (e.g., headaches, nausea, muscle soreness) are usually minor but are frequent side effects of ECT.  Lasting up to several hours, but occasionally longer.  A soft bite block or other such device is used to prevent injury to the tongue or teeth
  • 25. ECT Stimulus  Generation & behaviour of electrical stimulus has been conceptualized by Ohm’s law:  V (voltage) = I (current) × R (resistance)
  • 26. 1. Waveform of the stimulus:  Earlier ECT machines delivered current in the form of sine waves.  The slow rising and trailing edges of the sine wave do not produce efficient cerebral stimulation.  This delivers substantial amounts of electrical stimulation below seizure threshold and continues stimulation even while the neuronal tissue is in post-depolarization refractory period.
  • 27.  This may increase the cognitive adverse effects without enhancing the benefits.  Hence, the sine wave has been modified to eliminate the rising and trailing edges, retaining only the peaks in the form of ‘rectangular’ pulses
  • 28.  Stimulus is given in the form of brief pulses (0.5ms) with no stimulus in between the pulses.  Intermittent stimulation using pulses is more efficient as it allows the tissue to recover from post-depolarization refractory period.  Brief pulse ECT is able to induce seizures with substantially less charge and energy compared to sine wave.
  • 29.  Pulse width – 0.5-2ms: brief pulse <0.5ms: ultra-brief  Stimulus duration - total period for which the stimulus train is applied Sine wave – less than 1s Pulse wave – 0.5 – 8s  In the brief pulse ECT, the actual duration of stimulus will be even lesser if the inter-train interval (where stimulus is not provided) is excluded.
  • 30. Frequency - number of cycles per second (Hz)  In the transformer-based sine wave stimuli, this is always the line frequency (50Hz or 60 Hz)  Brief pulse – pulses per second (PPS) Directionality & Polarity : Stimulus in ECT is bidirectional, alternating current
  • 31. Pulse amplitude:  The amplitude of the delivered current is an important determinant of the volume of nervous tissue that is directly stimulated by the ECT.  Modern ECT uses a constant current of around 800- 900mA
  • 32. Charge:  Total amount of electrons traversing the inter-electrode tissue  It is the product of current and actual duration of stimulus in milli-Coulomb (mC)  Charge = current (in Amperes) × pulse width (in milliseconds) × pulse frequency × length of train (in seconds)
  • 33. 2. STIMULUS INTENSITY  Determines treatment efficacy & cognitive adverse effects; measured as charge in mC  Stimulus threshold should be supra-threshold to be efficacious  Bilateral ECT – 1.5 to 2.5 times threshold  Unilateral ECT – 2.5 to 6 times threshold
  • 34. 3. ELECTRODE PLACEMENT Unilateral ECT  Stimulus is provided to only one hemisphere (usually right) to minimize cognitive dysfunction  Electrode 1: Fronto-temporal site i.e., 1 inch above the midpoint of an imaginary line linking the outer canthus and the external auditory meatus  Electrode 2: 1 inch lateral to the vertex position, on the same side (usually right)
  • 35. Bilateral ECT  Bifrontal placement - electrodes are placed 5 cm vertically above the outer canthus of each eye along an imaginary vertical line perpendicular to a line connecting the pupils  Bitemporal placement - electrodes are placed on the frontotemporal sites, one on each side
  • 36. Electrode Placements Bitemporal Right unilateral / d’Elia Bifrontal / Letemendia
  • 37. Selective Preferences Of Electrode Placement Unilateral ECT • Concern about potential cognitive side-effects (children, elderly, brain damaged) • Instrument limitations (e.g., sine wave stimulus) Bilateral ECT • Mania or schizo-affective disorder • Patient has not satisfactorily responded to UL ECT (usually after 6 ECTs) • When more urgent response is essential (suicidal, starving etc)
  • 38. 4. FREQUENCY OF TREATMENTS  ECT is generally administered twice or thrice a week  However, it is recommended that the patient be evaluated both for therapeutic and adverse effects 5. NUMBER OF SESSIONS  Decided based on the degree and rate of clinical improvement and adverse effects  A typical course of ECT for depression consists of 6 to 12 sessions
  • 39.  Continuation ECT - begins after the index course, lasts up to 6 months, and is designed to prevent relapse of the episode  Maintenance ECT - to prevent further episodes for longer periods  Frequency of ECT is slowly tapered off to once a month
  • 40. ECT Procedure  Administration of ECT without a muscle relaxant is known as unmodified ECT.  In modified ECT, anesthesia, muscle relaxant, and the seizure-eliciting electrical stimulus are administered in the same order.  Use of a muscle relaxant prevents musculoskeletal injuries resulting from peripheral seizures
  • 41. Preparation of patient:  Avoid solid food for at least 6 hours before treatment.  Moderate amounts of clear fluids can be taken till 2 hours  Oral medications should be taken 2 hours before treatment  Pass urine to prevent bladder rupture during ECT.  Dentures, jewellery, hair clips, contact lenses and hearing aids should be removed.  Hair should be dry and clean.
  • 42. Modification Procedures:  Short acting barbiturates are commonly used as induction agents. E.g: Thiopentone (3-5 mg/kg)  Succinylcholine (0.5-1 mg/kg) is the preferred muscle relaxant due to its rapid onset, short duration of action, and rapid recovery.  Patient is allowed to breathe 100% oxygen through face mask for 3 minutes at 15 -20 breaths per minute
  • 43.  Atropine (0.6 mg) given along with intravenous anesthetic helps in preventing vagal effects of electrical stimulation on heart  Seizure Monitoring: 1. Cuff method 2. EEG monitoring
  • 44.  Cuff method: Technique  Place the BP cuff (preferably between knee and ankle). If unilateral ECT is used cuff should be attached to the right side (ipsilateral) to confirm generalization of seizures.  Just prior to the injection of succinylcholine inflate the cuff to a pressure 50 - 80 mm Hg above systolic blood pressure.
  • 45.  Observe that fasciculation after succinylcholine injection, which appear in other parts of the body do not appear in the isolated limb.  Apply the stimulus and note the time.  At the start of tonic phase of seizure release the cuff.  Record the total duration of tonic and clonic phases till the last clonic movement
  • 46. EEG monitoring:  Although not mandatory, it has distinct advantages and is recommended where possible as it is the most direct measure of cerebral activity available.  The length of the convulsions measured by direct visualization is approximately 70% that of EEG seizures
  • 47. Schematic of various phases of a typical ECT seizure.
  • 48. Motor and EEG ictal responses during ECT Stage Motor response EEG response Onset- epileptic recruiting rhythm - 10 Hz waves with increasing amplitude Tonic phase- polyspikes Tonic muscular contractions Bursts of high amplitude spike discharges lasting 10- 15 seconds Tonic –clonic phase – polyspike and slow wave complexes Regular myoclonic contractions Polyspikes intermixed with slow waves Post- ictal cortical extinction Post-ictal sleep Isoelectric or flat EEG Recovery Gradual regaining of consciousness Resumption of delta, then theta & then alpha activity
  • 49. Determination of Seizure Adequacy  Achievement of an adequate seizure duration has been assumed to be both necessary and sufficient to ensure therapeutic adequacy of ECT treatment  20- second motor response and/or  25-second EEG response
  • 50. Other Physiological Monitoring:  Vital signs such as Blood pressure and Pulse should be recorded before and after ECT.  ECG monitoring is considered mandatory during ECT procedure.  Pulse oximetry
  • 51.  Missed seizure, inadequate and prolonged seizures are known phenomena during ECT.  These are dependent on the seizure threshold.  The threshold is lower in a) young subjects, b) manic patients, and c) during the first ECT session.  Conversely, benzodiazepines, carbamazepine and thiopentone elevate the threshold.
  • 52. Missed seizures:  When electrical stimulation is not followed by any motor or EEG seizure activity, it is termed a missed seizure.  Wait for 20 seconds before restimulation to allow for delayed onset of seizures.  Restimulation should occur only after 45 seconds with higher dosage.
  • 53. Methods of managing missed seizure :  Change of anesthetic agent to Etomidate or Ketamine  Vigorous hyperventilation  Use of EEG monitoring  Change to bilateral ECT, as the seizure threshold is high with unilateral ECT  Reducing the frequency of sessions
  • 54.  Reducing the frequency of sessions (from 3/wk to 2/wk) can facilitate adequate seizures  Lower change rate by shortening pulse width or increasing interpulse intervals by decreasing frequency of stimulus  Avoiding / reducing the dosage of Anti-epileptics and Benzodiazepines.
  • 55. Prolonged seizure:  In most situations, the seizure terminates within 100 seconds.  The American Psychiatric Association task force defines a prolonged seizure if seizure duration is beyond 180 seconds.  Prolonged seizures can be terminated by intravenous diazepam 10 mg. or thiopentone 100-200mg
  • 56. Mechanisms of action of ECT Mechanisms of action of ECT have been studied in five important domains: 1. Neuroplasticity 2. Contribution of EEG correlates 3. Neurophysiology 4. Neurotransmitters 5. Neuroendocrinology
  • 57. Neuroplasticity:  This happens through remodelling of synapses, generation of new neurons, proliferation of glial cells, and improvement in blood supply in specific brain areas.  Animal studies have more robust findings favouring the role of ECT in promoting neuroplasticity, particularly in hippocampus, and recently in the prefrontal cortex and amygdala also
  • 58.  Serum levels of BDNF, an important neurotrophin regulating synaptogenesis and neuronal cell growth, have been found to be increased following ECT.  One study demonstrated increases in volumes of amygdala and prefrontal cortex.
  • 59. Contribution of EEG correlates : Anticonvulsant theory:  Gradual increase in seizure threshold occurs over the course of successive ECT sessions.  The plasma levels of inhibitory neurotransmitter GABA has been noted to increase following ECT  Hence, it has been postulated that the clinical improvements following ECT are not due to seizure per se, but due to the brain’s efforts to reduce the probability of occurrence of subsequent seizures
  • 60. Connectivity Resetting :  This is supported by the finding that ECT leads to frequency specific modification of theta activity and reduced blood flow in the Subgenual, ACC, Medial frontal cortex, and increased blood flow to the Thalamus  Thus, it is postulated that ECT rectifies the aberrant modulatory activity of alpha and theta oscillations by the thalamus.
  • 61.  It stimulates the thalamo-cortical loop, takes over the thalamic pacemaker function, resets it, and restores the functional connectivity and control between various brain areas.
  • 62. Neurophysiology:  The related hypothesis is called “Reducing Hyperconnectivity”.  ECT produces post-ictal states of diffuse slowing of EEG with high amplitude delta and theta activity.  This is followed by a period of post-ictal suppression, which initially lasts for few hours after each ECT session.
  • 63.  This slowing gradually prolongs over many sessions of ECT into an inter-ictal suppression  PET and SPECT studies have also shown decreased blood flow and glucose metabolism in the frontal lobe, following ECT.  Functional MRI studies are few, but they have corroborated the reduced functional connectivity in frontal cortex post-ECT.
  • 64.  Overall, it can be assumed that ECT reduces the “hyperconnectivity” secondary to depression in the frontal cortex, particularly in the VMPFC, DMPFC, and some parts of ACC.
  • 65. Neurotransmitters :  ECT has been found to affect 5-HT, DA, and adrenergic system. More pronounced on DA than on 5-HT and adrenaline.  Increased dopamine release consistently in the striatum, and inconsistently in the frontal and occipital regions.  It also causes up-regulation of DRD1 and DRD3 receptors
  • 66.  There is evidence of inhibition of adrenergic α2 auto receptors by ECT, resulting in increased secretion of catecholamines.  ECT increases concentrations of glutamine, (a metabolite of glutamate) and N-acetyl aspartate, a neuronal marker in the ACC, PFC, and amygdala. This supports the neuroplastic hypothesis of ECT.  ECT also increases GABA levels, particularly in ACC, PFC, and occipital cortex, thus reinforcing the anticonvulsant hypothesis.
  • 67. Neuroendocrinology:  Neuroendocrine-diencephalic theory of depression hypothesized that the HPA axis is disturbed producing a state of hypercortisolemia and abnormal DST  ACTH, cortisol and prolactin levels increased soon after a session of ECT and came down to normal level within few hours.  Normalisation of DST has been correlated with clinical response
  • 68. Major depressive disorder  ECT was found to be 20 to 40% more effective than medications  Response to ECT in antidepressant non-responders is around 50 to 70 % Effectiveness of ECT
  • 69.  Comparison of ECT versus antidepressants (MAOI & TCA) - a significant superior effect of ECT noted - Gangadhar BN et al (1982), Pagnin D et al  An RCT found ECT to be superior to paroxetine in medication-resistant major depression, in terms of both degree and speed of response - Folkerts HW et al  Equal efficacy in unipolar & bipolar depression – - Narayanaswamy JC et al
  • 70.  ECT is an effective short-term treatment for depression, and is probably more effective than drug therapy. Bilateral ECT is moderately more effective than unilateral ECT, and high dose ECT is more effective than low dose - UK ECT Review Group.
  • 71. Mania:  Second-line treatment (CANMAT, APA), third-line (NICE)  Response rates 75-80%; Increased responsiveness in rapid cyclers & mixed affective states  Controlled retrospective comparisons have found ECT to be equivalent to lithium, & at least as efficacious as typical neuroleptics
  • 72. Schizophrenia:  Indicated in treatment-resistant patients and those who relapse on monotherapy  Combination treatment is more effective than ECT alone, & more effective than medications alone  Equivalent to pharmacotherapy in management of NMS; superior in that it treats underlying condition where neuroleptics cannot be used
  • 73.  Response to ECT among a group of adolescents was around 76%. The main diagnosis was schizophrenia & MDD - Grover et al, 2013  Another study on children with a predominant diagnosis of catatonia showed ECT was efficacious in 77.3% patients – Jacob et al, 2014
  • 74. Delirium tremens:  ECT is an effective method of suppressing the symptoms of delirium associated with alcohol withdrawal  In all cases, one treatment produced a period of sedation followed by a clearing of the sensorium and termination of hallucinations within 24 hours. -William H. C. Dudley, Jr. and J. G. Williams
  • 75. ECT in Special Populations Elderly population: ECT is particularly useful in the elderly  Medication intolerance is common  Drug interactions are common  Cognitive side effects are more common  Response to ECT is better in the elderly  Seizure threshold is greater ⇒ It may be difficult to get adequate seizures
  • 76. Pregnancy:  Use of psychotropics is associated with problems in first and last trimester  Untreated psychiatric disorders may have adverse effect on the baby  ECT is effective  Many guidelines on mood disorders advocate use of ECT as first line treatment for major depression and mania in first trimester
  • 77.  APA Taskforce on ECT: “low risk and high efficacy in the management of specific disorders in all three trimesters of pregnancy”
  • 78. Children and adolescents:  ECT should be used with extreme caution (and very rarely as a first-line treatment) in young people because of the lack of evidence from randomised controlled trials  Seizure threshold is low  Propensity for prolonged seizures  Two consultants need to independently opinion about the need for ECT
  • 79. Relapse after ECT  51.1% of patients (depression) relapsed by 12 months following successful initial treatment with ECT, with the majority (37.7%) relapsing within the first 6 months -Ana Jelovac et al  C-ECT and continuation pharmacotherapy may be more effective than either alone for preventing relapse. -Nagy A. Youssef et al
  • 80. References:  Gangadhar BN, Sundar AS, Thirthalli J, Varambally S, Muralidharan J, Kumar CN et al. ECT Administration manual. 2nd ed. Bangalore: NIMHANS; 2013  Max Fink. Convulsive therapy: a review of the first 55 years. Journal of Affective Disorders 63 (2001) 1–15  UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003 Mar 8;361(9360):799-808  Gangadhar BN, Viswanath B, Keshavan M, Sundar AS. Hnadbook of Electroconvulsive therapy. Bangalore: NIMHANS; 2015.
  • 81.  Ziad Nahas, Jeffrey P. Lorberbaum, Frank A. Kozel, Mark S. George. Somatic Treatments In Psychiatry. Textbook of Biological Psychiatry. Wiley-Liss. 2004. 521-48.  Mankad MV, Beyer JL, Weiner RD, Krystal AD. Clinical Manual of Electroconvulsive Therapy. First Edition. . Washington DC. American Psychiatric Publishing; 2010  Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38(12):2467-74.  Youssef NA, McCall WV. Relapse prevention after index electroconvulsive therapy in treatment-resistant depression. Ann Clin Psychiatry. 2014;26(4):288-96.
  • 82.  Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004 Mar;20(1):13-20.  Gangadhar BN, Kapur RL, Kalyanasundaram S. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry 1982 Oct; 141():367-71.  Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze- Mönking H. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression -- a randomized study. Acta Psychiatr Scand 1997 Nov;96(5):334-42.  Grover S, Malhotra S, Varma S, Chakrabarti S, Avasthi A, Mattoo SK. Electroconvulsive therapy in adolescents: A retrospective study from north India. J ECT 2013;29:122-6.
  • 83.  Narayanaswamy JC, Viswanath B, Reddy PV, Kumar KR, Thirthalli J, Gangadhar BN. Efficacy of ECT in bipolar and unipolar depression in a real life hospital setting. Asian J Psychiatry 2104;8:43-6.  William H. C. Dudley, J. G. Williams. Electroconvulsive Therapy in Delirium Tremens. Comprehensive Psychiatry, Vol.13, No.4 (July/August),1972  Jacob P, Gogi PK, Srinath S, Thirthalli J, Girimaji S, Seshadri S, et al. Review of electroconvulsive therapy practice from a tertiary child and adolescent psychiatry centre. Asian J Psychiatr 2014;12:95-9.

Editor's Notes

  1. PAC every 6 months